Fukumoto Shoko, Nakamura Yuri, Watanabe Mitsuru, Isobe Noriko, Matsushita Takuya, Sakoda Ayako, Hiwatashi Akio, Shinoda Koji, Yamasaki Ryo, Tsujino Akira, Kira Jun-Ichi
Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; Department of Neurology, Fukuoka Central Hospital, International University of Health and Welfare, Fukuoka, Japan.
J Neurol Sci. 2020 Jun 15;413:116768. doi: 10.1016/j.jns.2020.116768. Epub 2020 Mar 4.
The effects of distinct HLA alleles on the brain and lesion volumes remain to be established, particularly in non-Caucasian populations. Two distinct susceptibility alleles, DRB115:01 and DRB104:05, are prevalent in the Japanese population; we therefore aimed to clarify the effects of HLA-DRB1 alleles on brain and lesion volumes in multiple sclerosis (MS).
A total of 66 patients with MS (50 relapsing remitting, 16 progressive) underwent brain MRI volumetry measuring fluid-attenuated inversion recovery (FLAIR) and T1 lesion volumes, and normalized whole-brain (NWBV), white matter (NWMV), gray matter (NGMV), cortical gray matter (NCGMV), deep gray matter (NDGMV) and thalamus (NTV) volumes, and HLA-DRB1 genotyping.
Carriers of HLA-DRB115:01(+)04:05(-) and HLA-DRB115:01(-)04:05(+) comprised 25.8% and 31.8% of patients, respectively. HLA-DRB115:01 carriers showed negative correlations between disease duration and NWBV (r = -0.484, p = .036), NWMV (r = -0.593, p = .008), and NTV (r = -0.572, p = .011), and positive correlations between disease duration and FLAIR (r = 0.539, p = .017) and T1 lesion volumes (r = 0.545, p = .016). By contrast, no significant correlation of any MRI parameters with disease duration was found in HLA-DRB104:05 carriers. HLA-DRB115:01 carriers had a significantly faster reduction in NWBV and NWMV by disease duration and smaller NDGMV than DRB115:01 non-carriers, whereas HLA-DRB104:05 carriers had a significantly slower increase in FLAIR and T1 lesion volumes than HLA-DRB104:05 non-carriers.
Our study suggests that distinct HLA-DRB1 alleles could differentially influence brain and lesion volumes over the disease course of MS.
不同的人类白细胞抗原(HLA)等位基因对脑容量和病灶体积的影响尚待确定,尤其是在非白种人群体中。两种不同的易感等位基因,DRB115:01和DRB104:05,在日本人群中普遍存在;因此,我们旨在阐明HLA-DRB1等位基因对多发性硬化症(MS)患者脑容量和病灶体积的影响。
共有66例MS患者(50例复发缓解型,16例进展型)接受了脑部磁共振成像(MRI)容积测定,测量了液体衰减反转恢复(FLAIR)和T1加权像上的病灶体积,以及标准化全脑(NWBV)、白质(NWMV)、灰质(NGMV)、皮质灰质(NCGMV)、深部灰质(NDGMV)和丘脑(NTV)体积,并进行了HLA-DRB1基因分型。
HLA-DRB115:01(+)04:05(-)和HLA-DRB115:01(-)04:05(+)携带者分别占患者的25.8%和31.8%。HLA-DRB115:01携带者的病程与NWBV(r = -0.484,p = 0.036)、NWMV(r = -0.593,p = 0.008)和NTV(r = -0.572,p = 0.011)呈负相关,与FLAIR(r = 0.539,p = 0.017)和T1加权像上的病灶体积(r = 0.545,p = 0.016)呈正相关。相比之下,在HLA-DRB104:05携带者中,未发现任何MRI参数与病程有显著相关性。与DRB115:01非携带者相比,HLA-DRB115:01携带者的NWBV和NWMV随病程的减少明显更快,NDGMV更小;而HLA-DRB104:05携带者的FLAIR和T1加权像上的病灶体积增加明显比HLA-DRB104:05非携带者慢。
我们的研究表明,不同的HLA-DRB1等位基因在MS病程中可能对脑容量和病灶体积产生不同影响。